HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shamshad Zarina Selected Research

Therapeutics

7/2023Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach.
1/2023Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics.
7/2018Two for one: Viral helicases as an ideal target for HIV and HCV co-infection.
1/2016Serum Paraoxonase Activity and Malondialdehyde Serum Concentrations Remain Unaffected in Response to Hydroxyurea Therapy in β-Thalassemia Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shamshad Zarina Research Topics

Disease

7Squamous Cell Carcinoma of Head and Neck
07/2023 - 03/2014
6Cataract (Cataracts)
05/2016 - 10/2006
4Neoplasms (Cancer)
01/2023 - 03/2014
4Thalassemia
01/2022 - 01/2016
4Hepatocellular Carcinoma (Hepatoma)
06/2020 - 01/2014
3Mouth Neoplasms (Oral Cancer)
07/2023 - 07/2020
3Chronic Renal Insufficiency
05/2017 - 01/2008
2Inborn Genetic Diseases (Disease, Hereditary)
12/2021 - 01/2019
2beta-Thalassemia (Cooley's Anemia)
12/2021 - 01/2019
1Neoplasm Metastasis (Metastasis)
07/2023
1Carcinogenesis
07/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2021
1Coinfection
07/2018
1Hyperglycemia
07/2012

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2008
5Aryldialkylphosphatase (Paraoxonase)IBA
05/2016 - 06/2007
4AntioxidantsIBA
05/2016 - 10/2006
3ProteomeIBA
07/2023 - 01/2014
3GlobinsIBA
12/2021 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2016
3Alendronate (Alendronate Sodium)FDA LinkGeneric
06/2018 - 01/2014
2ErbB Receptors (EGF Receptor)IBA
07/2023 - 06/2022
2Blood Proteins (Serum Proteins)IBA
01/2022 - 05/2017
2Hydroxyurea (Hydrea)FDA LinkGeneric
01/2019 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 07/2012
2arylesteraseIBA
01/2016 - 04/2009
2Malondialdehyde (Propanedial)IBA
01/2016 - 06/2007
2Peptides (Polypeptides)IBA
08/2015 - 01/2008
2EnzymesIBA
07/2012 - 10/2006
1Temozolomide (Temodar)FDA LinkGeneric
01/2023
1Alkylating AgentsIBA
01/2023
1Pamidronate (Aredia)FDA LinkGeneric
01/2023
1Methylphenidate (Ritalin)FDA LinkGeneric
12/2021
1Type II Keratins (Type II Keratin)IBA
01/2021
1Serum AlbuminIBA
01/2021
1HaptoglobinsIBA
01/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2021
1Glutathione Transferase (Glutathione S-Transferase)IBA
06/2020
1Therapeutic UsesIBA
06/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2020
1Hemoglobins (Hemoglobin)IBA
01/2019
1FluoroquinolonesIBA
07/2018
1Mevalonic Acid (Mevalonate)IBA
06/2018
1FTI 277IBA
06/2018
1Terpenes (Terpenoids)IBA
06/2018
1Fetal Hemoglobin (Hemoglobin F)IBA
01/2016
1Hemoglobin AIBA
01/2016
1Indicators and Reagents (Reagents)IBA
03/2014
1NitrogenIBA
01/2014
1Glutathione (Reduced Glutathione)IBA
07/2012
1polyolIBA
07/2012
1Advanced Glycation End ProductsIBA
09/2011
1oxidized low density lipoproteinIBA
06/2007
1Free RadicalsIBA
10/2006
1Xanthine OxidaseIBA
10/2006
1Superoxide Dismutase-1IBA
10/2006

Therapy/Procedure

4Therapeutics
07/2023 - 01/2016
2Lenses
07/2012 - 10/2006